Qilu Pharmaceutical (Inner Mongolia) Co., Ltd (hereinafter referred as "Qilu Inner Mongolia), founded in March, 2009 and locates south to Hohhot city, Inner Mongolia, North of China, is a subsidiary company of Qilu Pharmaceutical Group Company, serve as fermentation production base of the Group, which is top 5 among Chinese pharmaceutical industry in 2018.  

Qilu Inner mongolia has been focus on advanced biological technology to produce bio-agrichemicals and veterinary API for crop and animal protection use to increase production of agriculture, secure food supply of the world.

Qilu Pharmaceutical (Inner Mongolia) Co., Ltd.

ABOUT US

Qilu Inner Mongolia product line are (1) bio-agrichemicals of spinosad 92%, abamectin 95%, abamectin B2a 90% (2) veterinary API of spinosad 93%, tylosin tartrate, tylosin phosphate, tylosin base, tilmicosin base, tilmicosin phosphate (3) medicated premix of zinc bacitration 15% 10%, bacitration methyle disalicylate(BMD) 10% 15%, enramycin 4% 8%, chlortetracycline 15% 20%.

Our strength come from our ability of integrating our advanced fermentation technology, huge fermentation capacity, sustainable management of Q-EHS to get a comprehensive competitiveness to support our customers to get more benefit and faster development by share of product chain value with customers.

We are open minded to cooperate with customers, partners, friend all over the world on product development, registration, distribution, tech transfer, etc. based on win-win strategy, from cooperation all parties can get benefit and develop faster and soundly.

Welcome to Qilu Inner Mongolia to see by your own eyes, we believe you are more confident to cooperate with us.